How many insider trades does FilingIQ track for PAVM?

FilingIQ tracks 186 Form 4 insider transactions for PAVM (PAVmed Inc.), covering filings from May 17, 2016 onwards. 10 of those were filed in the last 90 days.

Are PAVM insiders net buyers or net sellers?

Across the full Form 4 history for PAVM, 124 transactions (67%) were open-market purchases and 8 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PAVM insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PAVM in?

PAVmed Inc. (PAVM) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $8.37M.

PAVM insider trading

NasdaqCM Healthcare

PAVmed Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

186

Last 90 days

Buys / sells

67% / 4%

Market cap

$8.37M

About PAVmed Inc.

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York

Company website: www.pavmed.com

PAVM insider activity at a glance

FilingIQ has scored 186 insider transactions for PAVM since May 17, 2016. The most recent filing in our index is dated Apr 2, 2026.

Across the full history, 124 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PAVM insider trades is 64.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PAVM trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for PAVM?: FilingIQ tracks 186 Form 4 insider transactions for PAVM (PAVmed Inc.), covering filings from May 17, 2016 onwards. 10 of those were filed in the last 90 days.
Are PAVM insiders net buyers or net sellers?: Across the full Form 4 history for PAVM, 124 transactions (67%) were open-market purchases and 8 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PAVM insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PAVM in?: PAVmed Inc. (PAVM) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $8.37M.

Methodology & sources

Every PAVM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.